Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zogenix Inc (NQ: ZGNX ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 4, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zogenix Inc < Previous 1 2 Next > The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO March 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings March 20, 2022 Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... Via Benzinga Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates March 02, 2022 The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies. Agios... Via Benzinga Merger Arbitrage Mondays - Healthcare Trust Of America To Combine With Healthcare Realty Trust March 07, 2022 Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced were potential deals in the works. Healthcare Trust... Via Benzinga Recap: Zogenix Q4 Earnings February 28, 2022 Zogenix (NASDAQ:ZGNX) reported its Q4 earnings results on Monday, February 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them? February 17, 2022 Can the formerly red-hot biotech segment return to its previous glory? Via Investor's Business Daily The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More January 23, 2022 Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that... Via Talk Markets The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More January 23, 2022 Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the... Via Benzinga Mid-Afternoon Market Update: Dow Tumbles 150 Points; Yumanity Therapeutics Shares Plunge January 19, 2022 Toward the end of trading Wednesday, the Dow traded down 0.45% to 35,210.04 while the NASDAQ fell 0.28% to 14,466.47. The S&P also fell, dropping, 0.29% to 4,563.94. The U.S.... Via Benzinga SBEV Stock: The Ralph’s Grocery Deal Making Waves for Splash Beverage Group Today January 19, 2022 Splash Beverage (SBEV) stock is soaring higher on Wednesday after the company revealed a new deal bringing its drinks to additional stores. Via InvestorPlace 52 Biggest Movers From Yesterday January 20, 2022 Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 19, 2022 Gainers Zogenix (NASDAQ:ZGNX) shares moved upwards by 67.2% to $26.15 during Wednesday's regular session. As of 12:30 EST, Zogenix's stock is trading at a volume... Via Benzinga Mid-Day Market Update: US Stocks Turn Negative; Zogenix Shares Spike Higher January 19, 2022 Midway through trading Wednesday, the Dow traded down 0.13% to 35,321.51 while the NASDAQ fell 0.53% to 14,430.41. The S&P also fell, dropping, 0.19% to 4,568.33. The U.S. has... Via Benzinga Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX January 19, 2022 From Halper Sadeh LLP Via Business Wire GENI Stock: The Analyst Call Sending Genius Sports Shares Surging Today January 19, 2022 Genius Sports (GENI) stock is on the rise Wednesday after an analyst initiated coverage of the sports data and tech company. Via InvestorPlace 35 Stocks Moving In Wednesday's Mid-Day Session January 19, 2022 Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion. Splash Beverage Group,... Via Benzinga ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today January 19, 2022 Zogenix (ZGNX) stock is skyrocketing on Wednesday following news that UCB (UCBJY) intends to acquire the company in a $1.9 billion deal. Via InvestorPlace Mid-Morning Market Update: Markets Rise; Bank of America Posts Upbeat Profit January 19, 2022 Following the market opening Wednesday, the Dow traded up 0.12% to 35,411.14 while the NASDAQ rose 0.90% to 14,638.13. The S&P also rose, gaining, 0.44% to 4,597.47. The U.S.... Via Benzinga Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest January 19, 2022 The deal includes a CVS tied to Fintepla's next potential approval. Via Investor's Business Daily Why Zogenix Shares Are Soaring Today January 19, 2022 Zogenix Inc (NASDAQ: ZGNX) is trading significantly higher Wednesday morning after the company announced it received a proposal to be acquired by UCB for approximately $... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 19, 2022 Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday January 19, 2022 Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday! Via InvestorPlace 20 Stocks Moving in Wednesday's Pre-Market Session January 19, 2022 Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose... Via Benzinga UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights January 19, 2022 Belgian-based UCB SA (OTC: UCBJF) has agreed to buy Zogenix Inc (NASDAQ: ZGNX), a U.S. maker of drugs to treat seizures and rare diseases, for $1.9 billion,... Via Benzinga Why Are Zogenix's Shares Gaining Today? December 01, 2021 The FDA has granted Priority Review to Zogenix Inc's (NASDAQ: ZGNX) supplemental marketing application seeking approval for Fintepla (fenfluramine) in... Via Benzinga Exposures Product Safety 61 Biggest Movers From Yesterday December 02, 2021 Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Recap: Zogenix Q3 Earnings November 04, 2021 Zogenix (NASDAQ:ZGNX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Zogenix... Via Benzinga Zogenix Earnings Preview November 03, 2021 Zogenix (NASDAQ:ZGNX) is set to give its latest quarterly earnings report on Thursday, 2021-11-04. Here's what investors need to know before the announcement. Analysts estimate... Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session December 01, 2021 Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's... Via Benzinga Topics Intellectual Property Exposures Intellectual Property The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.